ResearcherZhejiang Chinese Medical UniversityNo recent work listed
Yafang Qian
Matched on ORCID iD 0000-0002-9089-505X; OpenAlex author ID A5050856986. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 2
- Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling. Co-author DOI 10.1016/j.phymed.2021.153537↗
- Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling. Co-author DOI 10.3892/or.2016.4958↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mancang Gu · 2 shared papers, 2016–2021 · strength 0.20
- Paper Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling. DOI 10.1016/j.phymed.2021.153537↗
- Paper Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogati… DOI 10.3892/or.2016.4958↗
- Di Feng · 1 shared paper, 2021 · strength 0.12
- Liping Chen · 1 shared paper, 2021 · strength 0.12
- Yifan Qian · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.